Skip to content

Outset Medical, Inc. OM Additional Paid-In Capital

Additional Paid-In Capital at other companies

Baxter International logo
Baxter InternationalBAX
$6.21B-1.5%
DaVita logo
DaVitaDVA
$0-100%
Medtronic logo
MedtronicMDT
$20.93B+0.4%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$118.71M+3.3%
Haemonetics logo
HaemoneticsHAE
$554.14M+5.9%
CorMedix logo
CorMedixCRMD
$574.94M+32.6%

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-75.5%
Enterprise value$151.13M-61.9%
P/S0.7×-2.1×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Reported directly by Outset Medical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s additional paid-in capital?
Outset Medical, Inc. (OM) reported additional paid-in capital of $1.3B in Q1 2026.
How has Outset Medical, Inc.'s additional paid-in capital changed year-over-year?
Outset Medical, Inc.'s additional paid-in capital increased by 1.6% year-over-year, from $1.28B to $1.3B.
What is the long-term trend for Outset Medical, Inc.'s additional paid-in capital?
Over 5 years (2020 to 2025), Outset Medical, Inc.'s additional paid-in capital has grown at a 9.6% compound annual growth rate (CAGR), from $822.62M to $1.3B.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.